Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke

Scott E Kasner; John F Rhodes; Grethe Andersen; Helle K Iversen; Jens E Nielsen-Kudsk; Magnus Settergren; Christina Sjöstrand; Risto O Roine; David Hildick-Smith; J David Spence; Lars Søndergaard; Gore REDUCE Clinical Study Investigators

doi:10.1056/NEJMc2033779

Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke

Scott E Kasner, John F Rhodes, Grethe Andersen, Helle K Iversen, Jens E Nielsen-Kudsk, Magnus Settergren, Christina Sjöstrand, Risto O Roine, David Hildick-Smith, J David Spence, Lars Søndergaard, Gore REDUCE Clinical Study Investigators

34 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The New England journal of medicine
Vol/bind	384
Udgave nummer	10
Sider (fra-til)	970-971
Antal sider	2
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMc2033779
Status	Udgivet - 2021

Adgang til dokumentet

10.1056/NEJMc2033779

Citationsformater

Kasner, S. E., Rhodes, J. F., Andersen, G., Iversen, H. K., Nielsen-Kudsk, J. E., Settergren, M., Sjöstrand, C., Roine, R. O., Hildick-Smith, D., Spence, J. D., Søndergaard, L., & Gore REDUCE Clinical Study Investigators (2021). Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke. The New England journal of medicine, 384(10), 970-971. https://doi.org/10.1056/NEJMc2033779

Kasner, SE, Rhodes, JF, Andersen, G, Iversen, HK, Nielsen-Kudsk, JE, Settergren, M, Sjöstrand, C, Roine, RO, Hildick-Smith, D, Spence, JD, Søndergaard, L & Gore REDUCE Clinical Study Investigators 2021, 'Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke', The New England journal of medicine, bind 384, nr. 10, s. 970-971. https://doi.org/10.1056/NEJMc2033779

@article{89d4e7c82bfa4f5aa855923869367364,

title = "Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke",

keywords = "Follow-Up Studies, Foramen Ovale, Patent/complications, Humans, Ischemic Stroke/etiology, Platelet Aggregation Inhibitors/adverse effects, Secondary Prevention, Septal Occluder Device/adverse effects",

author = "Kasner, {Scott E} and Rhodes, {John F} and Grethe Andersen and Iversen, {Helle K} and Nielsen-Kudsk, {Jens E} and Magnus Settergren and Christina Sj{\"o}strand and Roine, {Risto O} and David Hildick-Smith and Spence, {J David} and Lars S{\o}ndergaard and {Gore REDUCE Clinical Study Investigators}",

year = "2021",

doi = "10.1056/NEJMc2033779",

language = "English",

volume = "384",

pages = "970--971",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke

AU - Kasner, Scott E

AU - Rhodes, John F

AU - Andersen, Grethe

AU - Iversen, Helle K

AU - Nielsen-Kudsk, Jens E

AU - Settergren, Magnus

AU - Sjöstrand, Christina

AU - Roine, Risto O

AU - Hildick-Smith, David

AU - Spence, J David

AU - Søndergaard, Lars

AU - Gore REDUCE Clinical Study Investigators

PY - 2021

Y1 - 2021

KW - Follow-Up Studies

KW - Foramen Ovale, Patent/complications

KW - Humans

KW - Ischemic Stroke/etiology

KW - Platelet Aggregation Inhibitors/adverse effects

KW - Secondary Prevention

KW - Septal Occluder Device/adverse effects

U2 - 10.1056/NEJMc2033779

DO - 10.1056/NEJMc2033779

M3 - Letter

C2 - 33704944

SN - 0028-4793

VL - 384

SP - 970

EP - 971

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 10

ER -